Everninomicin D

CO[C@H]([C@]1([C@@]2([H])[C@](OCO2)([H])[C@]3(OC1)O[C@]4([H])[C@@](CO[C@H]([C@@H]4OC)O[C@H]5[C@H]([C@H]([C@@H]([C@H](O5)COC)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)C)OC)O[C@H]7C[C@@]8([C@@](O[C@]9(C[C@H]([C@@H]([C@H](O9)C)O[C@H]%10C[C@H]([C@@H]([C@H](O%10)C)OC(C%11=C(C(Cl)=C(C(Cl)=C%11C)O)OC)=O)O[C@H]%12C[C@@](C)([C@H]([C@@H](O%12)C)OC)N(=O)=O)O)O8)([H])[C@H](O7)C)C)O)O)OC)([H])O3)O)C

[1]D R Foster, et al. Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family. Pharmacotherapy. 1999 Oct;19 (10) :1111-7.